Gapping up
In reaction to strong earnings/guidance: RGDX +18.8%, PGN +16.6%, PERY +16.4%, CTRP +13.9%, SHAK +6.8%, NTES +4.7%, MXPT +4%, TGB +3.6%, YOD +3.2%, EYES +2.8%, VIPS +1.8%, MSLI +1.7%, TNK +1.5%, CAAS +1.4%, STOR +1.2%, BCLI +1.1%, TCON +1.1%, JD +0.7%, JACK +0.6%, MORE +0.6%, VWR +0.6%
M&A news: ISSI +6.9% (Cypress Semiconductor (CY) sent letter to the Board of Integrated Silicon Solution offering to acquire 100% of its outstanding shares of common stock for $19.75 per share in cash), CY +2.8% (Sends Letter To Board Of Directors Of Integrated Silicon Solution, offers to purchase ISSI for $19.75 per share )
Select metals/mining stocks trading higher: MT +6.9%, AKS +2.8%, NOR +2.3%, X +2%, CLF +1.9%, SLV +1.5%, GOLD +1.1%, SLW +1%, AG +1%
Other news: CYRN +19.3% (agreement with Dell that adds CYREN's antimalware technology to Dell SonicWALL Email Security appliances, software, virtual appliances and hosted services), ACRX +19.3% (discloses entry into an award contract supported by the United States Army Medical Research and Materiel Command), ONTY +15.5% (Two abstracts related to ONT-380 for the treatment of breast cancer published), VBLT +11% (to present positive Phase 1/2 data for VB-111 in recurrent platinum-resistant Mullerian cancer at ASCO), WLT +9.6% (disclosed that on May 7, 2015, Brian M. Chopin, Assistant Corporate Controller was appointed Acting Corporate Controller and Chief Accounting Officer, effective May 20, 2015), DSCO +9.6% (reports top line data from its AEROSURF Phase 2a clinical trial), NVGN +5.9% (announces that it has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model), QIWI +4.4% (announces entrance into an agreement with Otkritie Financial Group to acquire its Contact money transfer and Rapida payment processing systems ), NOG +4.3% (priced its private offering of $200 mln in 8% senior notes due 2020 at 95% of par), TGTX +3.6% (announced clinical data presentations at ASCO; shares up ~3.6% in after hours trade), NBG +3.6% (optimistc tone from Greece Fin Min in comments today), MNKD +3.3% (still checking), SAM +2.1% (increases limit for stock repurchase program by additional $50 mln, bringing total limit to $400 million ), SAM +2.1% (increased limit for stock repurchase program by additional $50 mln, bringing total limit to $400 million), REN +2.1% (cont strength), STM +1.9% (CY/ISSI peer), SHPG +1.8% (still checking), NICE +1.7% (cont strength), INFN +1.6% (CY/ISSI peer), ASML +1.4% (CY/ISSI peer), SGMO +1.3% (will consolidate development plans for its zinc finger nuclease-mediated genome editing programs ) COWN +1.1% (prices offering of $105 million of shares of 5.625% Series A Cumulative Perpetual Convertible Preferred Stock), SPB +0.9% (priced 5,405,405 shares of common stock $92.50 per share)
Analyst comments: AKBA +5.1% (initiated with a Buy at Brean Capital), TSEM +4.5% (target raised to $28 from $24 at Ascendiant Capital Markets; also announced they have collaborated w UCSB to demonstrate the first 256-element), CWST +3.5% (upgraded to Outperform from Mkt Perform at Raymond James), ATML +2.7% (upgraded to Overweight from Equal Weight at a boutique firm), EURN +2.3% (initiated with a Outperform at Credit Suisse), KATE +1.7% (initiated with a Outperform at Wedbush), LLTC +1.6% (upgraded to Neutral from Underweight at JP Morgan), KMX +1.1% (initiated with a Buy at Sterne Agee CRT), DD +1% (upgraded to Neutral from Underperform at BofA/Merrill)